Synthetic Biologics, Inc.
BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY
Last updated:
Abstract:
This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).
Status:
Application
Type:
Utility
Filling date:
8 Dec 2021
Issue date:
31 Mar 2022